In August, Jefferies reiterated Orthofix's "buy" rating, according to News Den.
Here are three updates:
1. Jeffries presently has a $48 price target on Orthofix shares.
2. In July, Sidoti gave the shares a "buy rating."
3. Sidoti has a $43 price target on the company's shares.
More device news:
Titan Spine launches nanoLOCK surface technology nationwide: 5 highlights
Dr. Steven C. Schallhorn tapped as CMO of global ophthalmic devices for Carl Zeiss Meditec: 3 thoughts
Medtronic, Depuy Synthes lead cervical total disc replacement device market: 6 observations